![](/img/cover-not-exists.png)
A Phase II Study of XELOX and Cetuximab as First-Line Therapy in Patients With KRAS Wild Type Metastatic Colorectal Cancer (FLEET2 Study)
Hazama, Shoichi, Maeda, Hiromichi, Iwamoto, Shigeyoshi, Kim, Ho Min, Takemoto, Hiroyoshi, Kobayashi, Kenji, Sakamoto, Junichi, Nagata, Naoki, Oba, Koji, Mishima, HideyukiLanguage:
english
Journal:
Clinical Colorectal Cancer
DOI:
10.1016/j.clcc.2016.07.003
Date:
July, 2016
File:
PDF, 680 KB
english, 2016